{"pageContent": "Purpose: We investigated the potential for improvement in disease control by use of autologous peripheral blood stem cell transplant (PBSCT) to permit administration of high activities of (186)Re-hydroxyethylidene diphosphonate (HEDP) in patients with progressive hormone-refractory prostate cancer (HRPC).", "metaData": {"source": "Epidemiology of prostatitis: new evidence for a world-wide problem\nhttps://pubmed.ncbi.nlm.nih.gov/12712363/"}}